Cargando…
Application of nano‐radiosensitizers in combination cancer therapy
Radiosensitizers are compounds or nanostructures, which can improve the efficiency of ionizing radiation to kill cells. Radiosensitization increases the susceptibility of cancer cells to radiation‐induced killing, while simultaneously reducing the potentially damaging effect on the cellular structur...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189501/ https://www.ncbi.nlm.nih.gov/pubmed/37206240 http://dx.doi.org/10.1002/btm2.10498 |
_version_ | 1785043102259478528 |
---|---|
author | Varzandeh, Mohammad Sabouri, Leila Mansouri, Vahid Gharibshahian, Maliheh Beheshtizadeh, Nima Hamblin, Michael R. Rezaei, Nima |
author_facet | Varzandeh, Mohammad Sabouri, Leila Mansouri, Vahid Gharibshahian, Maliheh Beheshtizadeh, Nima Hamblin, Michael R. Rezaei, Nima |
author_sort | Varzandeh, Mohammad |
collection | PubMed |
description | Radiosensitizers are compounds or nanostructures, which can improve the efficiency of ionizing radiation to kill cells. Radiosensitization increases the susceptibility of cancer cells to radiation‐induced killing, while simultaneously reducing the potentially damaging effect on the cellular structure and function of the surrounding healthy tissues. Therefore, radiosensitizers are therapeutic agents used to boost the effectiveness of radiation treatment. The complexity and heterogeneity of cancer, and the multifactorial nature of its pathophysiology has led to many approaches to treatment. The effectiveness of each approach has been proven to some extent, but no definitive treatment to eradicate cancer has been discovered. The current review discusses a broad range of nano‐radiosensitizers, summarizing possible combinations of radiosensitizing NPs with several other types of cancer therapy options, focusing on the benefits and drawbacks, challenges, and future prospects. |
format | Online Article Text |
id | pubmed-10189501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101895012023-05-18 Application of nano‐radiosensitizers in combination cancer therapy Varzandeh, Mohammad Sabouri, Leila Mansouri, Vahid Gharibshahian, Maliheh Beheshtizadeh, Nima Hamblin, Michael R. Rezaei, Nima Bioeng Transl Med Review Articles Radiosensitizers are compounds or nanostructures, which can improve the efficiency of ionizing radiation to kill cells. Radiosensitization increases the susceptibility of cancer cells to radiation‐induced killing, while simultaneously reducing the potentially damaging effect on the cellular structure and function of the surrounding healthy tissues. Therefore, radiosensitizers are therapeutic agents used to boost the effectiveness of radiation treatment. The complexity and heterogeneity of cancer, and the multifactorial nature of its pathophysiology has led to many approaches to treatment. The effectiveness of each approach has been proven to some extent, but no definitive treatment to eradicate cancer has been discovered. The current review discusses a broad range of nano‐radiosensitizers, summarizing possible combinations of radiosensitizing NPs with several other types of cancer therapy options, focusing on the benefits and drawbacks, challenges, and future prospects. John Wiley & Sons, Inc. 2023-02-10 /pmc/articles/PMC10189501/ /pubmed/37206240 http://dx.doi.org/10.1002/btm2.10498 Text en © 2023 The Authors. Bioengineering & Translational Medicine published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Articles Varzandeh, Mohammad Sabouri, Leila Mansouri, Vahid Gharibshahian, Maliheh Beheshtizadeh, Nima Hamblin, Michael R. Rezaei, Nima Application of nano‐radiosensitizers in combination cancer therapy |
title | Application of nano‐radiosensitizers in combination cancer therapy |
title_full | Application of nano‐radiosensitizers in combination cancer therapy |
title_fullStr | Application of nano‐radiosensitizers in combination cancer therapy |
title_full_unstemmed | Application of nano‐radiosensitizers in combination cancer therapy |
title_short | Application of nano‐radiosensitizers in combination cancer therapy |
title_sort | application of nano‐radiosensitizers in combination cancer therapy |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189501/ https://www.ncbi.nlm.nih.gov/pubmed/37206240 http://dx.doi.org/10.1002/btm2.10498 |
work_keys_str_mv | AT varzandehmohammad applicationofnanoradiosensitizersincombinationcancertherapy AT sabourileila applicationofnanoradiosensitizersincombinationcancertherapy AT mansourivahid applicationofnanoradiosensitizersincombinationcancertherapy AT gharibshahianmaliheh applicationofnanoradiosensitizersincombinationcancertherapy AT beheshtizadehnima applicationofnanoradiosensitizersincombinationcancertherapy AT hamblinmichaelr applicationofnanoradiosensitizersincombinationcancertherapy AT rezaeinima applicationofnanoradiosensitizersincombinationcancertherapy |